Диссертация (1140145), страница 27
Текст из файла (страница 27)
Pernicious anemia and Helicobacter pylori infection in Japan: evaluationin a country with a high prevalence of infection // Am J Gastroenterol. – 1995. –Vol.90. – P.1107–10.88) Hershko C., Hoffbrand A.V., Keret D. , Souroujon M., Maschler I. , Monselise Y.,Lahad A.
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in162refractory or unexplained iron deficiency anemia // Haematologica. – 2005. – Vol.90.– P.585–95.89) Hershko C., Patz J., Ronson A. The anemia of achylia gastrica revisited // BloodCells Mol Dis. – 2007.
– Vol.39. – P.178–83.90) Hershko C., Ronson A., Souroujon M., Maschler I., Heyd J., Patz J. Variablehematologic presentation of autoimmune gastritis: age-related progression from irondeficiency to cobalamin depletion // Blood. – 2006. – Vol.107. – P.1673–9.91) Hirschowitz B.I., Griffith J., Pellegrin D., Cummings O.W.
Rapid regression ofenterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy //Gastroenterology. – 1992. – Vol.102. – P.1409–18.92) Hølleland G., Schneede J., Ueland P.M., Lund P.K., Refsum H., Sandberg S.Cobalamin Deficiency in General Practice. Assessment of the Diagnostic Utility andCost-Benefit Analysis of Methylmalonic Acid Determination in Relation to CurrentDiagnostic Strategies // Clin Chem. – 1999. – Vol.45.
– P.189–198.93) Hsing A.W., Hansson L.E., McLaughlin J.K., Nyren O., Blot W.J., EkbomA., Fraumeni J.F. Jr. Pernicious anemia and subsequent cancer. A population-basedcohort study // Cancer. – 1993. – Vol.71. – P.745–50.94) Hvas A.M., Nexo E. Diagnosis and treatment of vitamin B12 deficiency. An update// Haematologica. – 2006. – Vol.9. – P.1506–1512.95) Iijima K., Abe Y., Kikuchi R., Koike T., Ohara S., Sipponen P., Shimosegawa T.Serum biomarker tests are useful in delineating between patients with gastric atrophyand normal, healthy stomach // World J Gastroenterol. – 2009. – Vol.15.
– P.853–9.96) Irvine W.J. Clinical and pathological significance of parietal cell antibodies // ProcR Soc Med. – 1966. – Vol.59. – P.695–8.97) Irvine WJ, Davies SH, Teitelbaum S, Delamore IW, Williams AW. The clinicaland pathological significance of gastric parietal cell antibody // Ann N Y Acad Sci.– 1965.
– Vol.124. – P.657–691.98) Ito M., Haruma K., Kaya S., Kamada T., Kim S., Sasaki A., Sumii M., Tanaka S.,Yoshihara M., Wagner S., Chayama K. Serological comparison of serum pepsinogen163and anti-parietal cell antibody levels between Japanese and German patients // Eur JGastroenterol Hepatol.
– 2002. – Vol.14. – P.123–7.99) Jeffries G.H., Todd J.E., Sleisenger M.H. The effect of prednisolone on gastricmucosal histology, gastric secretion, and vitamin B 12 absorption in patients withpernicious anemia // J Clin Invest. – 1966. – Vol.45. – P.803–12.100) Johnson-Wimbley T.D., Graham D.Y. Diagnosis and management of irondeficiency anemia in the 21st century // Ther Adv Gastroenterol. – 2011. – Vol.4. –P.177–184.101) Jordan P.H. Jr, Barroso A., Sweeney J.
Gastric carcinoids in patients withhypergastrinemia // J Am Coll Surg. – 2004. – Vol.199. – P.552–5.102) Kapadia C.R. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective // JClin Gastroenterol. – 2003. – Vol.36. – P.29–36.103) Karlsson F.A., Burman P., Loof L., Olsson M., Scheynius A., Mardh S. Enzymelinked immunosorbent assay of H+, K+-ATPase, the parietal cell antigen // Clin. exp.Immunol. – 1987.
– Vol.70. – P.604–610.104) Kasperlik-Zaluska A.A., Czarnocka B., Jeske W., Papierska L. Addison's DiseaseRevisited in Poland: Year 2008 versus Year 1990 // Autoimmune Dis.– 2010:731834.105) Kaye M.D. Immunological aspects of gastritis and pernicious anaemia // BaillieresClin Gastroenterol. – 1987. – Vol.1. – P.487–506.106) Kekki M., Varis K., Pohjanpalo H., Isokoski M., Ihamäki T., Siurala M.
Course ofantrum and body gastritis in pernicious anemia families // Dig Dis Sci. – 1983. –Vol.28. – P.698–704.107) Khan S., Del-Duca C., Fenton E., Holding S., Hirst J., Doré P.C., Sewell W.A.Limited value of testing for intrinsic factor antibodies with negative gastric parietalcell antibodies in pernicious anaemia // J Clin Pathol. – 2009.
– Vol.62. – P.439–41.108) Kirchner T., Faller G. Helicobacter pylori infections and autoimmunity: theinterplay in the pathogenesis of gastritis // Verh Dtsch Ges Pathol. – 1999. – Vol.83.– P.56–61.164109) Kohlstadt I.C., Antunez de Mayolo E.A., Ramirez-Icaza C. Parietal cell antibodiesamong Peruvians with gastric pathologic changes.
Gastrointestinal PhysiologyWorking Group // Scand J Gastroenterol. – 1993. – Vol.28. – P.973–7.110) Kokkola A., Sipponen P., Rautelin H., Härkönen M., Kosunen T.U., HaapiainenR., Puolakkainen P. The effect of Helicobacter pylori eradication on the natural courseof atrophic gastritis with dysplasia // Aliment Pharmacol Ther. – 2002.
– Vol.16. –P.515–20.111) Lahner E., Annibale B. Pernicious anemia: New insights from a gastroenterologicalpoint of view // World J Gastroenterol. – 2009. – Vol.15. – P.5121–5128.112) Lahner E., Caruana P., D'Ambra G., Ferraro G., Di Giulio E., Delle Fave G., BordiC., Annibale B. First endoscopic-histologic follow-up in patients with bodypredominant atrophic gastritis: when should it be done? // Gastrointest Endosc.– 2001. – Vol.53. – P.443–8.113) Lahner E., Norman G.L., Severi C., Encabo S., Shums Z., Vannella L., Delle FaveG., Annibale B.
Reassessment of intrinsic factor and parietal cell autoantibodies inatrophic gastritis with respect to cobalamin deficiency// Am J Gastroenterol. – 2009.– Vol.104. – P.2071–9.114) Lechner K., Födinger M., Grisold W., Püspök A., Sillaber C. Vitamin B12deficiency. New data on an old theme // Wien Klin Wochenschr. – 2005. – Vol.117.– P.579–91.115) Liaskos C., Norman G.L., Moulas A., Garagounis A., Goulis I., RigopoulouE.I., Dalekos G.N. Prevalence of gastric parietal cell antibodies and intrinsic factorantibodies in primary biliary cirrhosis // Clin Chim Acta.
– 2010. – Vol.411. – P.411–5.116) Lindenbaum J., Rosenberg I.H., Wilson P.W., Stabler S.P., Allen R.H. Prevalenceof cobalamin deficiency in the Framingham elderly population // Am J Clin Nutr.– 1994. – Vol.60. – P.2–11.117) Lo C.C., Hsu P.I., Lo G.H., Lai K.H., Tseng H.H., Lin C.K., Chan H.H., Tsai W.L.,Chen W.C., Peng N.J. Implications of anti-parietal cell antibodies and anti-165Helicobacter pylori antibodies in histological gastritis and patient outcome // World JGastroenterol.
– 2005. – Vol.11. – P.4715–20.118) Mackay I.R. Autoimmune serological studies in chronic gastritis and perniciousanaemia // Gut. – 1964. – Vol.5. – P.23–26.119) Macukanović-Golubović L., Katić V., Rancić G., Milenović M., MarjanovićG., Golubović Z. Study on histogenesis of enterochromaffin-like carcinoid inautoimmune atrophic gastritis associated with pernicious anemia // VojnosanitPregl.
– 2007. – Vol.64. – P.543–8.120) Malfertheiner P., Megraud F., O'Morain C.A., Atherton J., Axon A.T., BazzoliF., Gensini G.F., Gisbert J.P., Graham D.Y., Rokkas T., El-Omar E.M., KuipersE.J.; European Helicobacter Study Group. Management of Helicobacter pyloriinfection--the Maastricht IV/ Florence Consensus Report // Gut. – 2012. – Vol.61. –P.646–64.121) MårdhS., Ma J.Y., SongY.H., AlyA., HenrikssonK. Occurrenceofautoantibodies against intrinsic factor, H,K-ATPase, and pepsinogen in atrophicgastritis and rheumatoid arthritis // Scand J Gastroenterol.
– 1991. – Vol.26. – P.1089–96.122) Marignani M., Delle Fave G., Mecarocci S., Bordi C., Angeletti S., D'AmbraG., Aprile M.R., Corleto V.D., Monarca B., Annibale B. High prevalence of atrophicbody gastritis in patients with unexplained microcytic and macrocytic anemia: aprospective screening study // Am J Gastroenterol. – 1999.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
